The EPEAT Program ensures the ongoing conformance of EPEAT-registered products through a surveillance process known as Continuous Monitoring. Continuous Monitoring activities occur throughout the year and test the ability of Participating Manufacturers to prove conformance with EPEAT Criteria on an ongoing basis. All EPEAT-registered products in all product categories and all Participating Manufacturers are subject to Continuous Monitoring.

Les activités de contrôle continu comprennent des enquêtes planifiées par le programme EPEAT et mises en œuvre par les organismes d'assurance de la conformité (OEC) approuvés par le GEC dans des délais discrets appelés cycles de contrôle continu. Pour chaque cycle, le programme EPEAT spécifie les produits et les critères EPEAT à examiner, le calendrier spécifique des activités d'enquête et la méthode d'enquête que les OEC doivent utiliser.

To maintain the level of transparency relied on by purchasers, the EPEAT Program publishes an Outcomes Report at the conclusion of each Round to summarize the activities conducted and to identify the products and Participating Manufacturers that received nonconformances and the actions taken to restore the accuracy of the EPEAT Registry.

The Outcomes Reports for Continuous Monitoring Rounds CD-2022-01, and IE-2022-04 are now available on the EPEAT Registry. CD-2022-01 involved laboratory evaluation of EPEAT-registered products in the Computers and Displays product category against specific EPEAT Criteria. IE-2022-04 involved the review of documentary evidence provided by Participating Manufacturers to demonstrate conformance with the EPEAT Criteria in the Imaging Equipment product category.

Please contact us with any questions at